GlassScriptPhysician profile
Steven B Snyder
NPI 1285894618
$595.31
in general payments reported to CMS, 2019-2025
14 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $76.10 · 2021: $68.10 · 2022: $138 · 2023: $46.26 · 2024: $58.48 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $123.81 | 2019-2025 | |
| Abbvie INC. | $111.03 | 2019-2022 | |
| Intuitive Surgical, INC. | $66.81 | 2022 | |
| Minerva Surgical, INC | $56.84 | 2023-2025 | |
| Astellas Pharma US INC | $50.19 | 2023-2024 | Veozah |
| Alydia Health | $31.24 | 2021 | |
| Organon LLC | $23.80 | 2025 | Jada System |
| Acell, INC. | $23.21 | 2019 | |
| Roche Diagnostics Corporation | $22.77 | 2019 | |
| Mayne Pharma Commercial LLC | $20.75 | 2024 | |
| Sage Therapeutics, LLC | $18.75 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $17.15 | 2024 | Cologuard Collection Kit |
| Exeltis, USA INC. | $15.87 | 2020 | |
| Amgen INC. | $13.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.